Senores Pharmaceuticals Limited Stock: price and insider trades · India

Senores Pharmaceuticals Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). In the past year (24 October 2025 to 24 October 2026), 18 filings came from 12 insiders.

Only purchases show up on the open market, 7 purchases in all worth €85k, filed by 4 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 major shareholder. Renosen Pharmaceuticals Private Limited filed the largest purchase, €47k, on 1 January 2026.

Compared with its exchange (1,891 companies, median 4 filings), a count of 18 filings is above the norm. Our records for Senores Pharmaceuticals Limited go back to 2025, with 73 purchases and 3 sales on the open market in total.

In all, 5 purchases were made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 26 February 2026, 240 days ago. Typically, a trade is published a median of 3 days after it takes place. Until a filing is published, the market cannot know about the trade.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.